Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

被引：0
|
作者：
Sang-Won Lee
Hee-Jin Park
Beom Kyung Kim
Kwang-Hyub Han
Soo-Kon Lee
Seung Up Kim
Yong-Beom Park
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute for Immunology and Immunological Diseases
[3] Yonsei University College of Medicine,Department of Medical Sciences
[4] Yonsei University College of Medicine,Institute of Gastroenterology
[5] Yonsei University College of Medicine,Liver Cirrhosis Clinical Research Center
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Chronic Liver Disease; Liver Fibrosis; Cumulative Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function
    Park, Jin Su
    Park, Min-Chan
    Park, Yong-Beom
    Lee, Soo-Kon
    Lee, Sang-Won
    CLINICAL RHEUMATOLOGY, 2014, 33 (10) : 1415 - 1423
  • [2] Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function
    Jin Su Park
    Min-Chan Park
    Yong-Beom Park
    Soo-Kon Lee
    Sang-Won Lee
    Clinical Rheumatology, 2014, 33 : 1415 - 1423
  • [3] Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate
    Hilal, Ghizlane
    Akasbi, Nessrine
    Boudouaya, Hanae
    Salma, Ksir
    Harzy, Taoufik
    CURRENT RHEUMATOLOGY REVIEWS, 2020, 16 (04) : 293 - 297
  • [4] The relationship between dose of methotrexate and incidence of liver fibrosis in patients with rheumatoid arthritis
    Akbarirad, Mina
    Rezaieyazdi, Zahra
    Tajik, Ali
    Ataei, Banafshe
    Sarabi, Mehrdad
    Mehradmajd, Hasan
    Vossoughinia, Hasan
    Firoozi, Abdollah
    REUMATOLOGIA, 2025, 63 (01): : 3 - 11
  • [5] Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate
    Slouma, Maroua
    Lahmar, Wided
    Mohamed, Ghanem
    Dhrif, Omar
    Dhahri, Rim
    Bellali, Hedia
    Gharsallah, Imen
    Ebdelli, Nabil
    CLINICAL RHEUMATOLOGY, 2024, 43 (03) : 929 - 938
  • [6] Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate
    Maroua Slouma
    Wided Lahmar
    Ghanem Mohamed
    Omar Dhrif
    Rim Dhahri
    Hedia Bellali
    Imen Gharsallah
    Nabil Ebdelli
    Clinical Rheumatology, 2024, 43 : 929 - 938
  • [7] Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate
    Park, Sung-Hoon
    Choe, Jung-Yoon
    Kim, Seong-Kyu
    JOINT BONE SPINE, 2010, 77 (06) : 588 - 592
  • [8] Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis
    Mroczkowski, PJ
    Weinblatt, ME
    Kremer, JM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S66 - S68
  • [9] INCIDENCE OF HEPATOTOXICITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH METHOTREXATE AND LEFLUNOMIDE
    Agostina Gatica, Maria
    Cichillitti, Lucia
    Ringer, Ariana
    Pablo Ruffino, Juan
    Carbone, Dianela
    Abdala, Brian
    Lucci, Franco
    Gallo, Carolina
    Nicola, Marianela
    Abdala, Marcelo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S79 - S79
  • [10] Pancytopenia in rheumatoid arthritis patients receiving methotrexate
    Laroche, F
    Perrot, S
    Menkes, CJ
    REVUE DU RHUMATISME, 1996, 63 (05): : 381 - 382
12345